Monday, October 15, 2018
|
7:30 - 8:20 AM
|
Continental Breakfast and Registration
|
|
8:25 - 8:30 AM
|
UCSD/IGM Welcome and Opening Remarks
|
|
8:30 - 9:00 AM
|
Eugene Koonin, PhD | National Institute for Health
CRISPR-Cas systems: diverse functional connections and evolutionary trends |
|
9:00 - 9:30 AM
|
Rodolphe Barrangou, PhD | North Carolina State University
Characterization and applications of Type 1 and Type II CRISPR-Cas systems in bacteria and beyond |
|
9:30 - 10:00 AM
|
Karen Maxwell, PhD | University of Toronto
Naturally occurring off switches for CRISPR-Cas9 |
|
10:00 - 10:15 AM
|
Break
|
|
10:15 - 10:30 AM
|
Kevin Holden, PhD | Synthego
Synthetic sgRNA: Enabling Primary Cell Research, Screening Applications and a Novel Automation Platform for Engineering Cell Lines |
|
10:30 - 11:00 AM
|
Jonathan Weissman, PhD | University of California, San Francisco
Finding and interpreting genetics interactions using Perturb-seq single cell RNA-seq CRISPR screens |
|
11:00 - 11:30 AM
|
Danwei Huangfu, PhD | Memorial Sloan Kettering Cancer Center
Human development and disease through the lens of pluripotent stem cells |
|
11:30 - 12:00 PM
|
Chris Vakoc, PhD | Cold Spring Harbor Laboratories
Transcriptional vulnerabilities of cancer cells |
|
12:00 - 1:00 PM
|
Lunch Break
|
|
1:00 - 2:00 PM
|
Keynote: Jay Shendure, MD, PhD | University of Washington
Global views of development |
|
2:00 - 2:30 PM
|
Yvonne Chen, PhD | University of California, Los Angeles
Engineering next-generation T cells for cancer immunotherapy |
|
2:30 - 3:00 PM
|
Samira Kiani, MD | Arizona State University
Engineering CRISPR safety and controllability for in vivo applications |
|
3:00 - 3:15 PM
|
Break
|
|
3:15 - 3:30 PM
|
Illumina Talk
|
|
3:30 - 4:00 PM
|
Mitchell O'Connell, PhD | University of Rochester
Programmable RNA targeting by CRISPR-Cas enzymes |
|
4:00 - 4:30 PM
|
Alexis Komor, PhD | University of California, San Diego
Base Editing: Performing chemistry on the genome |
|
4:30 PM - 5:00 PM
|
Charles Gersbach, PhD | Duke University
Genome and epigenome editing for gene therapy, cell programming and functional genomics |
|
5:00 - 5:15 PM
|
Closing Remarks
|
|
5:15 - 6:30 PM
|
Reception
|
Join Us. |
Contact Us. |
